Extracellular vesicle-based nucleic acid delivery

被引:27
|
作者
Lu, Mei [1 ]
Shao, Wanxuan [1 ]
Xing, Haonan [2 ]
Huang, Yuanyu [1 ]
机构
[1] Beijing Inst Technol, Key Lab Mol Med & Biotherapy, Key Lab Med Mol Sci & Pharmaceut Engn, Adv Res Inst Multidisciplinary Sci,Sch Life Sci,S, Beijing 100081, Peoples R China
[2] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China
来源
INTERDISCIPLINARY MEDICINE | 2023年 / 1卷 / 02期
关键词
CRISPR/Cas systems; extracellular vesicles; mRNAs; nucleic acid delivery; siRNAs;
D O I
10.1002/INMD.20220007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Extracellular vesicles (EVs) are a heterogeneous class of natural vesicles that facilitate intercellular communication by functional transfer of lipids and biomolecular cargoes, such as miRNAs, mRNAs and proteins. As a naturally occurring delivery vehicle for nucleic acids, EVs are characterized by multiple advantageous characteristics, such as unique size and structure, excellent biocompatibility, immunologically inert, increased stability in circulation, intrinsic targeting capacity and the capability of membrane fusion and crossing biological barriers. Of note, the delivery properties of EVs can be further improved by genetic engineering of donor cells or direct modification of EVs. Over the last decade, EVs have sparkled intensive interest for delivery of small RNAs, including small interfering RNAs (siRNAs) and microRNAs (miRNAs). In recent years, increasing attention has been focused on exploring a variety of strategies to harness EVs for delivery of more nucleic acid types. In the present perspective, we provide a capsule overview of the latest accomplishments and trends in the field of EV-based delivery systems for siRNAs, miRNAs, messenger RNAs (mRNAs), clustered regularly interspaced short palindromic repeats-associated endonuclease (CRISPR/Cas) systems, antisense oligonucleotides (ASOs), circular RNA (circRNAs), long noncoding RNAs (lncRNAs) and DNAs. This perspective may offer insights into the rational design of more cutting-edge extracellular vesicle-based nucleic acid delivery nanoplatforms.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines
    Kuriyama, Naoya
    Yoshioka, Yusuke
    Kikuchi, Shinsuke
    Okamura, Akihiko
    Azuma, Nobuyoshi
    Ochiya, Takahiro
    CANCERS, 2021, 13 (23)
  • [2] Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies
    Massaro, Crescenzo
    Sgueglia, Giulia
    Frattolillo, Victoria
    Baglio, S. Rubina
    Altucci, Lucia
    Dell'Aversana, Carmela
    PHARMACEUTICS, 2020, 12 (10) : 1 - 19
  • [3] Extracellular vesicle-based drug delivery in cancer immunotherapy
    Najafi, Sajad
    Majidpoor, Jamal
    Mortezaee, Keywan
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2023, 13 (11) : 2790 - 2806
  • [4] Extracellular vesicle-based drug delivery systems for cancer treatment
    Walker, Sierra
    Busatto, Sara
    Pham, Anthony
    Tian, Ming
    Suh, Annie
    Carson, Kelsey
    Quintero, Astrid
    Lafrence, Maria
    Malik, Hanna
    Santana, Moises X.
    Wolfram, Joy
    THERANOSTICS, 2019, 9 (26): : 8001 - 8017
  • [5] Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines
    Kim, Oh Youn
    Lee, Jaewook
    Gho, Yong Song
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2017, 67 : 74 - 82
  • [6] Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy
    Chen, Hongyi
    Sun, Tao
    Jiang, Chen
    JOURNAL OF CONTROLLED RELEASE, 2022, 348 : 572 - 589
  • [7] Extracellular Vesicle-Based Hybrid Systems for Advanced Drug Delivery
    Rodriguez, Diego A.
    Vader, Pieter
    PHARMACEUTICS, 2022, 14 (02)
  • [8] Improved extracellular vesicle-based mRNA delivery for familial hypercholesterolemia treatment
    Yang, Zheng
    Ji, Panpan
    Li, Zhelong
    Zhang, Rongxin
    Wei, Mengying
    Yang, Yang
    Yuan, Lijun
    Han, Yan
    Yang, Guodong
    THERANOSTICS, 2023, 13 (10): : 3467 - 3479
  • [9] Extracellular Vesicle-Based Antitumor Nanomedicines
    Li, Mingfeng
    Liu, Yanfei
    Liu, Fei
    Chen, Qiwen
    Xu, Lishang
    Cheng, Zhongyu
    Tan, Yifu
    Liu, Zhenbao
    ADVANCED HEALTHCARE MATERIALS, 2025,
  • [10] Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
    Jiramonai, Luksika
    Liang, Xing-Jie
    Zhu, Mengliang
    PHARMACEUTICS, 2025, 17 (02)